Literature DB >> 15671770

Design of new questionnaires to measure quality of life and treatment satisfaction in hypothyroidism.

C V McMillan1, C Bradley, A Woodcock, S Razvi, J U Weaver.   

Abstract

INTRODUCTION: This paper reports work undertaken to design two new condition-specific questionnaires for use in hypothyroidism: the Underactive Thyroid-Dependent Quality of Life Questionnaire (ThyDQoL) and the Underactive Thyroid Treatment Satisfaction Questionnaire (ThyTSQ).
METHODS: Semistructured interviews exploring quality of life (QoL) and experiences of treatment were conducted with 30 women and 8 men with hypothyroidism, (mean age, 51.9; range, 29-79 years), 37 of 38 treated with thyroxine, recruited from hospital clinics and primary care.
RESULTS: Despite thyroxine treatment, most interviewees reported negative impact of hypothyroidism on QoL, particularly on energy, physical capabilities, motivation, physical appearance, and weight. The newly designed ThyDQoL has 18 domains covering these and other aspects of life affected by hypothyroidism. It is an individualized measure of patients' perceived impact of hypothyroidism on their QOL, which takes into account the importance of personally applicable life domains to the patient. A 7-item measure of satisfaction with current treatment was designed (ThyTSQ-Present) but interviews also indicated the need for a separate 4-item section measuring satisfaction with past treatment around the time of diagnosis (ThyTSQPast).
CONCLUSIONS: The ThyDQoL and ThyTSQ questionnaires have good face validity and content validity for adults with hypothyroidism. They are now ready for use in clinical research and psychometric evaluation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15671770     DOI: 10.1089/thy.2004.14.916

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  20 in total

Review 1.  Persistent hypothyroid symptoms in a patient with a normal thyroid stimulating hormone level.

Authors:  Jacqueline Jonklaas
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2017-10       Impact factor: 3.243

2.  Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement.

Authors:  Jacqueline Jonklaas; Antonio C Bianco; Andrew J Bauer; Kenneth D Burman; Anne R Cappola; Francesco S Celi; David S Cooper; Brian W Kim; Robin P Peeters; M Sara Rosenthal; Anna M Sawka
Journal:  Thyroid       Date:  2014-12       Impact factor: 6.568

Review 3.  Association of Thyroid Hormone Therapy With Quality of Life and Thyroid-Related Symptoms in Patients With Subclinical Hypothyroidism: A Systematic Review and Meta-analysis.

Authors:  Martin Feller; Marieke Snel; Elisavet Moutzouri; Douglas C Bauer; Maria de Montmollin; Drahomir Aujesky; Ian Ford; Jacobijn Gussekloo; Patricia M Kearney; Simon Mooijaart; Terry Quinn; David Stott; Rudi Westendorp; Nicolas Rodondi; Olaf M Dekkers
Journal:  JAMA       Date:  2018-10-02       Impact factor: 56.272

4.  Age-Related Serum Thyroid-Stimulating Hormone Reference Range in Older Patients Treated with Levothyroxine: A Randomized Controlled Feasibility Trial (SORTED 1).

Authors:  Salman Razvi; Vicky Ryan; Lorna Ingoe; Simon H Pearce; Scott Wilkes
Journal:  Eur Thyroid J       Date:  2019-11-21

5.  Optimal Thyroid Hormone Replacement.

Authors:  Jacqueline Jonklaas
Journal:  Endocr Rev       Date:  2022-03-09       Impact factor: 25.261

6.  Establishing construct validity for the thyroid-specific patient reported outcome measure (ThyPRO): an initial examination.

Authors:  Torquil Watt; Jakob Bue Bjorner; Mogens Groenvold; Ase Krogh Rasmussen; Steen Joop Bonnema; Laszlo Hegedüs; Ulla Feldt-Rasmussen
Journal:  Qual Life Res       Date:  2009-03-14       Impact factor: 4.147

7.  Feedback on the FDA's February 2006 draft guidance on Patient Reported Outcome (PRO) measures from a developer of PRO measures.

Authors:  Clare Bradley
Journal:  Health Qual Life Outcomes       Date:  2006-10-09       Impact factor: 3.186

Review 8.  Primary hypothyroidism and quality of life.

Authors:  Laszlo Hegedüs; Antonio C Bianco; Jacqueline Jonklaas; Simon H Pearce; Anthony P Weetman; Petros Perros
Journal:  Nat Rev Endocrinol       Date:  2022-01-18       Impact factor: 47.564

9.  Treated Autoimmune Thyroid Disease Is Associated with a Decreased Quality of Life among Young Persons with Type 1 Diabetes.

Authors:  Alena Spirkova; Petra Dusatkova; Monika Peckova; Stanislava Kolouskova; Marta Snajderova; Barbora Obermannova; Katerina Stechova; Tamara Hrachovinova; Jiri Mares; Ondrej Cinek; Jan Lebl; Zdenek Sumnik; Stepanka Pruhova
Journal:  Int J Endocrinol       Date:  2015-05-18       Impact factor: 3.257

10.  Patient-reported outcomes in adequately treated hypothyroidism - insights from the German versions of ThyDQoL, ThySRQ and ThyTSQ.

Authors:  Eva M Quinque; Arno Villringer; Juergen Kratzsch; Stefan Karger
Journal:  Health Qual Life Outcomes       Date:  2013-04-23       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.